The KALICOU 3 study will evaluate the effect of emotional skills of patients and their partners on their individual disease subjective experience during care pathways, from chemotherapy to surveillance.
All women with breast cancer have to face, at any age, to numerous issues linked to cancer (incertitude, recurrence anxiety...) and to physical and psychosocial side effects of treatments which can degrade their life quality. However, young women (\<45 years at diagnostic) have to face specific issues related to their age (early menopause, withdrawal of pregnancy projects, education of young children). Moreover, treatment consequences can alter patient's life quality and can persist in time (fatigue, pains, chemotherapy, sexuality, induced menopause for example). Overall, young patients have a lesser life quality, greater emotional distress and vulnerability and have more difficulties to establish adapted adjustment strategy compared to elder women. The role and importance of relatives, particularly partners, during cancer pathology is incontestable. However, few empiric and consensual data exist on the impact of cancer diagnostic on partners, especially when women are young at initial diagnostic. Nevertheless, available data underline the importance of the supporting partner during breast cancer disease. Cancer also disturbs conjugal relationship. For example, life quality of patient influence strongly the life quality and mental well-being of her partner. Moreover, the intimate relation with the partner could play an important role in healing after breast cancer. Numerous authors underline the importance of focus on the couple instead of patients alone or partners alone with a dyadic approach where dyad member's reactions will be interdependent. Thus, study of dyadic adjustment of couples where a member is facing cancer pathology at young age is indubitably innovative and present a real scientific and clinical interest. More precisely, KALICOU 3 study will focus on the impact of intrapersonal and interpersonal emotional skills of patients and partners on individual and dyadic adjustment.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
800
After patient and partner information, clinical research associate or clinical research nurse will give to the couple 2 booklets containing 5 questionnaires, respectively T1, T2, T3, T4 and T5.
T1 is to fill before chemotherapy.
T2 is to fill after the 6th cycle of chemotherapy.
BCI-YW ( Breast Cancer Inventory - Young Women)
To evaluate the effect of emotional skills of patients and partners on their individual disease subjective experience during care pathways, from chemotherapy to surveillance
Time frame: an average of 1 year
BCI-Partner's YW ( Breast Cancer Inventory - Young Women Partner's)
To evaluate the effect of emotional skills of patients and partners on their individual disease subjective experience during care pathways, from chemotherapy to surveillance
Time frame: an average of 1 year
PEC (Profile of Emotional Competences)
To evaluate the effect of emotional skills of patients and partners on their individual disease subjective experience during care pathways, from chemotherapy to surveillance
Time frame: an average of 1 year
BCI-YW
To evaluate the dyadic effect's emotional skills and treatment repercussion on adjustment to cancer as well as on partner
Time frame: an average of 1 year
BCI-Partner's YW
To evaluate the dyadic effect's emotional skills and treatment repercussion on adjustment to cancer as well as on partner
Time frame: an average of 1 year
SF 36 (Short Form 36 - Health Survey)
To evaluate the dyadic effect's emotional skills and treatment repercussion on adjustment to cancer as well as on partner
Time frame: an average of 1 year
Hospital Anxiety-Depression Scale
To evaluate the dyadic effect's emotional skills and treatment repercussion on adjustment to cancer as well as on partner
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
T3 is to fill at the end of radiotherapy.
T4 is to fill 4 month after beginning of hormonotherapy or surveillance if no hormonotherapy.
T5 is to fill 1 year after the beginning of hormonotherapy or surveillance if no hormonotherapy.
ICO-Site Paul Papin
Angers, France
RECRUITINGCentre Marie Curie
Arras, France
RECRUITINGInstitut Sainte Catherine
Avignon, France
RECRUITINGCentre Pierre Curie - SCP de radiologie et d'imagerie médicale
Beuvry, France
RECRUITINGPolyclinique Bordeaux Nord Aquitaine
Bordeaux, France
RECRUITINGCH de BOULOGNE-SUR-MER
Boulogne-sur-Mer, France
RECRUITINGCentre François Baclesse
Caen, France
RECRUITINGCentre Hôpitalier de Compiègne Noyon
Compiègne, France
RECRUITINGCentre Léonard de Vinci
Dechy, France
RECRUITINGCentre Georges François Leclerc
Dijon, France
RECRUITING...and 23 more locations
Time frame: an average of 1 year
Profile of Emotional Competences
To evaluate the dyadic effect's emotional skills on adjustment to cancer as well as on partner
Time frame: an average of 1 year
MAVA (Measure of affectivity: Valence/Activation)
To evaluate the dyadic effect's emotional skills on adjustment to cancer as well as on partner
Time frame: an average of 1 year